Pictet Asset Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.5M | Buy |
967,602
+94,380
| +11% | +$2.68M | 0.03% | 431 |
|
|
2025
Q1 | $25.8M | Buy |
873,222
+74,194
| +9% | +$2.19M | 0.03% | 429 |
|
|
2024
Q4 | $23.2M | Buy |
799,028
+12,548
| +2% | +$365K | 0.03% | 463 |
|
|
2024
Q3 | $36.1M | Buy |
786,480
+406,678
| +107% | +$18.7M | 0.04% | 351 |
|
|
2024
Q2 | $15.5M | Buy |
379,802
+368,930
| +3,393% | +$15.1M | 0.02% | 535 |
|
|
2024
Q1 | $277K | Buy |
+10,872
| New | +$277K | ﹤0.01% | 1581 |
|